CStone Pharmaceuticals (HKG:2616)

CStone Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,378	2,936	2,895	5,519	9,630	11,596
Market Cap Growth	298.60%	1.42%	-47.55%	-42.69%	-16.96%	11.17%
Enterprise Value	18,051	2,374	2,021	4,205	6,648	9,164
Last Close Price	12.61	2.30	2.27	4.63	8.27	10.08
PS Ratio	82.83	6.78	5.67	10.14	32.19	9.40
PB Ratio	53.24	7.58	5.75	10.87	6.50	3.31
P/TBV Ratio	105.14	13.62	9.26	16.86	6.90	3.31
EV/Sales Ratio	81.35	5.48	3.95	7.73	22.22	7.43
Debt / Equity Ratio	1.24	0.98	0.80	0.64	0.14	0.03
Asset Turnover	0.15	0.27	0.28	0.25	0.08	0.31
Inventory Turnover	1.38	0.85	2.44	4.86	-	-
Quick Ratio	1.20	1.18	1.44	1.29	2.03	4.91
Current Ratio	1.44	1.60	1.56	1.32	2.10	4.91
Return on Equity (ROE)	-96.36%	-22.23%	-81.05%	-109.00%	-92.28%	-44.92%
Return on Assets (ROA)	-16.92%	-3.90%	-21.93%	-29.16%	-37.90%	-20.33%
Return on Capital (ROIC)	-30.55%	-7.74%	-46.53%	-53.86%	-51.74%	-24.71%
Earnings Yield	-2.25%	-3.31%	-13.98%	-18.49%	-24.47%	-12.50%
FCF Yield	-	-12.44%	-22.41%	-12.51%	-20.08%	-5.89%
Buyback Yield / Dilution	-1.61%	-1.04%	-7.69%	-0.66%	-11.39%	-20.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.